The Jaguar Health Inc (NASDAQ: JAGX) stock seems to be in focus among investors during premarket trading this morning.
JAGX stock has soared by as big as 15% amid considerable interest and it might be a good idea for investors to perhaps keep track of it today. Yesterday, the company announced its financial results for the year that ended on December 31, 2020. Jaguar Health announced that the net sales of its product Mytesi touched around $9.3 million while the gross sales came in at around $20.4 million.
Those figures reflect a rise of as high as 64% and 148% year on year respectively. It is an impressive performance from the company and might have been one of the major reasons behind the rally in the stock this morning. On the other hand, it should be noted that Jaguar Health had kept the animal product research and development initiatives to the bare minimum. Consequently, the sales in that segment were also low.
Finance and Entertainment Reporter
Richard is a bottle of wine – the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.